• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Tigecycline for treatment of multidrug-resistant gram-negative bacteria in transplant recipient patients: Challenges of antimicrobial susceptibility testing.

作者信息

Sfeir Maroun M

机构信息

Department of Pathology and Laboratory Medicine, University of Connecticut Health Center, Farmington, CT, USA.

出版信息

Transpl Infect Dis. 2020 Apr;22(2):e13254. doi: 10.1111/tid.13254. Epub 2020 Feb 16.

DOI:10.1111/tid.13254
PMID:32017304
Abstract
摘要

相似文献

1
Tigecycline for treatment of multidrug-resistant gram-negative bacteria in transplant recipient patients: Challenges of antimicrobial susceptibility testing.替加环素用于治疗移植受者患者的多重耐药革兰氏阴性菌：抗菌药物敏感性试验的挑战
Transpl Infect Dis. 2020 Apr;22(2):e13254. doi: 10.1111/tid.13254. Epub 2020 Feb 16.
2
Effectiveness of tigecycline in the treatment of infections caused by carbapenem-resistant gram-negative bacteria in pediatric liver transplant recipients: A retrospective study.替加环素治疗小儿肝移植受者耐碳青霉烯类革兰阴性菌感染的有效性：一项回顾性研究。
Transpl Infect Dis. 2020 Feb;22(1):e13199. doi: 10.1111/tid.13199. Epub 2019 Nov 1.
3
Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial.2012-2016 年间收集的革兰氏阳性和革兰氏阴性血源性病原体的抗菌药敏性，作为替加环素评估和监测试验的一部分。
Antimicrob Resist Infect Control. 2018 Dec 13;7:152. doi: 10.1186/s13756-018-0441-y. eCollection 2018.
4
Antimicrobial susceptibility of Gram-negative and Gram-positive bacteria collected from Eastern Europe: Results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.), 2011-2016.革兰氏阴性菌和革兰氏阳性菌对来自东欧的抗生素敏感性：替加环素评估和监测试验（T.E.S.T.），2011-2016 年的结果。
J Glob Antimicrob Resist. 2019 Jun;17:44-52. doi: 10.1016/j.jgar.2018.11.007. Epub 2018 Nov 13.
5
Bad bug, no test: Tigecycline susceptibility testing challenges and way forward.危险病菌，无检测方法：替加环素药敏试验面临的挑战及未来方向
Indian J Med Microbiol. 2019 Jan-Mar;37(1):91-94. doi: 10.4103/ijmm.IJMM_19_207.
6
Antimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial.2005年至2012年期间在墨西哥收集的革兰氏阳性和阴性临床分离株的抗菌药敏趋势：替加环素评估与监测试验的结果
Ann Clin Microbiol Antimicrob. 2015 Dec 15;14:53. doi: 10.1186/s12941-015-0116-y.
7
In-vitro activity of tigecycline against multidrug-resistant Gram negative bacteria: The experience of a university hospital.替加环素对多重耐药革兰氏阴性菌的体外活性：一家大学医院的经验。
J Infect Public Health. 2021 Apr;14(4):478-483. doi: 10.1016/j.jiph.2020.12.013. Epub 2021 Mar 17.
8
Susceptibility to tigecycline of isolates from samples collected in hospitalized patients with secondary peritonitis undergoing surgery.住院患者术后发生继发性腹膜炎时采集样本的分离株对替加环素的敏感性。
Diagn Microbiol Infect Dis. 2010 Mar;66(3):308-13. doi: 10.1016/j.diagmicrobio.2009.10.018.
9
Antimicrobial susceptibility of gram-negative and gram-positive bacteria collected from countries in Eastern Europe: results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) 2004-2010.东欧国家分离的革兰氏阴性和革兰氏阳性细菌的抗菌药物敏感性：来自替加环素评价和监测试验（T.E.S.T.）2004-2010 的结果。
Int J Antimicrob Agents. 2013 Jun;41(6):527-35. doi: 10.1016/j.ijantimicag.2013.02.022. Epub 2013 Apr 13.
10
Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial.作为替加环素评估与监测试验的一部分，2004年至2015年间从拉丁美洲地区收集的革兰氏阳性和革兰氏阴性生物体的抗菌药敏性。
Ann Clin Microbiol Antimicrob. 2017 Jul 12;16(1):50. doi: 10.1186/s12941-017-0222-0.